Terence Prudhomme of AT Activate Named 2026 Agency Vanguard Award Winner

AbelsonTaylor Group today announced that Terence Prudhomme, VP, Media Strategy at AT Activate, the agency’s full-service media strategy and buying unit, has been named a recipient of the 2026 DTC Perspectives Agency Vanguard Award. The honor recognizes exceptional agency professionals whose accomplishments and leadership are shaping the future of consumer health marketing and improving patient communications.

Prudhomme was recognized for his role in redefining how pharmaceutical brands approach media strategy—particularly those with modest budgets seeking to compete in a landscape traditionally dominated by large-scale spenders. His work has helped establish AT Activate as a model for audience-first, data-driven healthcare media planning.

In 2024, Prudhomme helped spearhead the development of AT Activate’s modern media strategy framework, designed to help healthcare brands reach patients and healthcare professionals with greater precision and efficiency. Campaigns leveraging the approach have delivered engagement rates 25–30% higher than previous benchmarks and cost efficiencies exceeding 20%, while increasing targeted audience exposure by 35%.

For one mid-tier pharmaceutical client, the strategy helped drive a 40% lift in brand awareness and a 15% increase in patient consultations within three months, demonstrating how thoughtful audience insights and integrated media execution can deliver measurable results without blockbuster budgets.

“Terence represents exactly the kind of innovative, audience-first thinking that defines AT Activate,” said Sara Brandt, SVP, Media, AT Activate. “He has an exceptional ability to connect data, creativity, and media strategy in ways that deliver meaningful results for our clients and, ultimately, better engagement with patients and healthcare professionals. This recognition is incredibly well deserved.”

A 15-year media and marketing professional, Prudhomme has built his career at the intersection of media innovation and healthcare communications. His approach emphasizes understanding the patient journey and identifying what he calls the “key aperture moments” when communications can most meaningfully influence healthcare decision-making.

In addition to his strategic work with clients, Prudhomme is an active industry thought leader who advocates for the democratization of advanced media capabilities within pharmaceutical marketing.

About AT Activate
AT Activate is the full-service media strategy and buying unit of AbelsonTaylor Group, a leading independent healthcare marketing communications agency. The AT Activate team partners with healthcare brands to design integrated, data-driven media strategies that connect scientific innovation with the audiences who need it most—delivering measurable business impact while advancing patient-centered communication.